- Home
- ENTA vs BSET Comparison
ENTA vs BSET Comparison
Compare ENTA & BSET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ENTA
- BSET
- Stock Information
- Founded
- ENTA 1995
- BSET 1902
- Country
- ENTA United States
- BSET United States
- Employees
- ENTA N/A
- BSET N/A
- Industry
- ENTA Biotechnology: Pharmaceutical Preparations
- BSET Home Furnishings
- Sector
- ENTA Health Care
- BSET Consumer Discretionary
- Exchange
- ENTA Nasdaq
- BSET Nasdaq
- Market Cap
- ENTA 164.6M
- BSET 135.3M
- IPO Year
- ENTA 2013
- BSET 1987
- Fundamental
- Price
- ENTA $11.81
- BSET $15.62
- Analyst Decision
- ENTA Strong Buy
- BSET
- Analyst Count
- ENTA 5
- BSET 0
- Target Price
- ENTA $20.20
- BSET N/A
- AVG Volume (30 Days)
- ENTA 1.1M
- BSET 23.6K
- Earning Date
- ENTA 08-11-2025
- BSET 10-13-2025
- Dividend Yield
- ENTA N/A
- BSET 5.06%
- EPS Growth
- ENTA N/A
- BSET N/A
- EPS
- ENTA N/A
- BSET 0.28
- Revenue
- ENTA $64,806,000.00
- BSET $326,469,000.00
- Revenue This Year
- ENTA N/A
- BSET $3.18
- Revenue Next Year
- ENTA $1.65
- BSET $3.57
- P/E Ratio
- ENTA N/A
- BSET $56.23
- Revenue Growth
- ENTA N/A
- BSET N/A
- 52 Week Low
- ENTA $4.09
- BSET $13.58
- 52 Week High
- ENTA $15.28
- BSET $19.75
- Technical
- Relative Strength Index (RSI)
- ENTA 61.09
- BSET 40.82
- Support Level
- ENTA $7.05
- BSET $15.51
- Resistance Level
- ENTA $15.34
- BSET $16.12
- Average True Range (ATR)
- ENTA 1.32
- BSET 0.52
- MACD
- ENTA 0.47
- BSET -0.06
- Stochastic Oscillator
- ENTA 53.86
- BSET 14.86
About ENTA Enanta Pharmaceuticals Inc.
Enanta Pharmaceuticals Inc is an American biotechnology company which uses robust, chemistry-driven approach and drug discovery capabilities to focus on the research and development of molecule drugs to cure viral infections and liver diseases. Uses virology and immunology method for curing the diseases. The targeted diseases are hepatitis C, hepatitis B, nonalcoholic steatohepatitis, and the respiratory syncytial virus. The novelty of company research is a specific direct-acting antiviral inhibitor against the hepatitis C virus. The company's inhibitors have been developed in collaboration with AbbVie. AbbVie markets the protease inhibitor, paritaprevir, while other inhibitors are in the pipeline.
About BSET Bassett Furniture Industries Incorporated
Bassett Furniture Industries Inc is a manufacturer, marketer, and retailer of home furnishings products in the United States. It operates through the following segments: The Wholesale segment focuses on the design, manufacture, sourcing, sale, and distribution of furniture products, the Retail segment which consists of company-owned stores, and the Corporate and others segment. Majority of revenue is from Wholesale sales of furniture and accessories.